我院2002年～2005年降糖药应用分析

Analysis of Hypoglycemic Drugs Used in Our Hospital During the Period 2002～2005

目的：了解我院降糖药应用情况并作出客观评估，以促进合理用药。方法：对我院2002年～2005年降糖药的销售金额、用药频度及限定日费用等进行统计分析。结果：4年采我院降糖药销售金额降幅较大，占药品总销售额的比例每年以30．40％的速度下降；降糖药销售金额排序，格列齐特连续3年稳居榜首；DDDs排序，二甲双胍、格列齐特分列前2位，诺和灵30R波动较大、呈先降后升之势；DDC排序稳定，依次为：格列吡嗪、诺和灵30R、阿卡波糖、格列喹酮、格列齐特、甲苯磺丁脲、二甲双胍、格列本脲。结论；我院降糖药合理使用水平需要进一步提高。

OBJECTIVE：To investigate the utilization of hypoglyeemic drugs in our hospital and to make an objective cavlumation so as to promote rational use of which in the clinic. METHODS： Statistical analysis was performed on hypoglyeemie drugs regarding the consumption sum, DDDs and DDC （defined daity cost） during the period 2002 - 2005. RESULTS： Over the four years, the consumption sum of hypoglyeemic drugs in our hospital expericenced a big reduction, with annmal deercase rate at 30.40% . Glielazide remained at the first place for 3 years in the sequence of the consumption sum of hypoglycemic drugs. Regarding the sequence of DDDs, metformin and glielazide dominated the first 2 places, but novlin 30R had a big fluctuation, which showed a reduction prior to increase. The DDC sequence has been table, leading the list in order were glipizide, novolin 30R, acarbose, gliquidone, glielazide, tolbutamide, metformin and glibenclamide. CONCLUSION： The use of hypoglyeemie drugs in our hospital remains to be further improved.